OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram (ECG) business strategy, ...

Secures FDA 510(K) Clearance For 12-Lead ECG Synthesis Software Following Successful Appeal. HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...

KUWAIT: Dr Mohammed Zubaid, Consultant Cardiologist and Vice President of the Kuwait Heart Association, affirmed that heart failure is a widespread condition, noting that it requires urgent medical ...

HeartBeam’s ECG software duplicates the 12-lead ECG approach undertaken in healthcare settings with electrodes to evaluate ...

AI, machine learning, and cloud platforms are reshaping remote patient monitoring. These technologies support predictive ...

HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...

HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac ...

London Ambulance Service shares a video of abuse paramedics face as they ask for “respect” for staff this Christmas. | ITV ...

Investing.com -- HeartBeam Inc (NASDAQ:BEAT) stock surged 52.6% in premarket trading Wednesday after the medical technology company announced it received FDA 510 (k) clearance for its 12-lead ...

A cardiologist at the University of Ilorin, Professor Ibraheem Katibi, has developed a locally artificial intelligence (AI) ...